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INTRODUCTION
Immature teratoma (IMT) is a tumor composed of tis-
sues from three germ layers (ectoderm, mesoderm, and 
endoderm), with immature or embryonic structures. 
This rare tumor comprises less than 1% of ovarian tu-
mors and is considered the second most common germ 
cell tumor1.
IMT accounts for 10-20% of all ovarian neoplasias 
in women less than 20 years of age, with peak incidence 
between 15 and 19 years old, and 30% of the deaths from 
ovarian cancer in this age group. IMT rarely occurs dur-
ing menopause2.
IMT may present as a calcified pelvic mass, abnor-
mal uterine bleeding, or pelvic pain. The most common 
sites of dissemination are the peritoneum and the retro-
peritoneal lymph nodes. Hematogenous spread to lungs, 
liver, or brain is unusual. They present elevated levels of 
alpha-fetoprotein in 50% of cases3.
These tumors are histologically graded (grades 1 to 3) 
based on the amount and degree of neuroepithelial cell 
component immaturity. Older patients tend to have low-
er-grade tumors than younger patients4. Immature tera-
tomas are rarely found bilaterally, while it is common to 
find benign teratomas in the contralateral ovary1.
Peritoneal implants may be present at the time of 
surgical procedure, and the prognosis is strongly relat-
ed to the histological grade of the tumor and implant 
(82% survival for patients with grade 1 lesions, 63% for 
grade 2 lesions, and 30% for grade 3 lesions)5.
A surgical approach is indicated for diagnosis, treat-
ment, and staging (even if used for other ovarian tu-
mors). Patients with completely resected tumors have 
approximately 94% chance of survival at five years, while 
patients with partial resection have a survival expecta-
tion of less than 50%. Because bilateralism is rare in this 
type of tumor, the surgery of choice consists of unilateral 
salpingo-oophorectomy with collection of samples from 
peritoneal implants6.
Radiotherapy does not appear to improve the progno-
sis of patients. There is no indication of therapy besides 
surgery for tumors limited to one ovary (grade 1), except 
in cases of capsular rupture or ascites. In tumors of grade 
2 or 3, or with bilateral implants or recurrences, adjuvant 
chemotherapy should be indicated in a regimen of vin-
cristine, actinomycin and cyclophosphamide (VAC), or 
bleomycin, etoposide and cisplatin7,8.
Some studies advocate the use of alternative regimens 
with paclitaxel-carboplatin or docetaxel-carboplatin in 
order to prevent reproductive toxicity in patients under-
going conservative surgery9.
Early diagnosis associated with immediate therapy 
and close follow-up are essential for long-term favorable 
outcomes10. Patients undergoing surgery with preserva-
tion of the uterus and of one ovary have normal repro-
ductive function11,12. The motivation for our case report is 
due to the rarity of bilateral immature teratomas, as well 
as the fact that the patient’s age is below the average for 
the occurrence of these tumors.
CASE REPORT
A.V.D.O, 12 years old, admitted to the Gynecologic On-
cology Service at Hospital das Clínicas Samuel Libânio 
– Universidade Vale do Sapucaí, with abnormal uterine 
bleeding for two months, associated with the presence of 
a pelvic mass. The patient had menarche at age 11 with 
irregular cycles, first sexual intercourse six months prior 
to admission, contraception with male condoms.
Physical examination revealed that the patient was in 
good general state; ruddy; with an abdominopelvic mass, 
extending to four centimeters below the costal margin, mo-
bile, and of solid-cystic consistency; hymenal membrane 
ruptured; slight vaginal bleeding; centralized cervix; circu-
lar external orifice; negative Schiller test, colposcopically 
normal. Gynecological examination revealed cervix of gy-
necologic consistency, and normal size uterus compressed 
to the right by the mass. Attachments not delimited.
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Figure 1 – Computed tomography of the abdomen showing 
a large complex abdominopelvic mass of probable ovarian 
etiology.
Figure 2 – Immature ovarian teratoma: macroscopic aspect.
Figure 3 – Photomicrographs of immature ovarian teratoma. 
On the left: an area of cartilage (C) and glandular tissue cys-
tically dilated (G), 150x. On the right:  portions of central 
nervous system tissue, 600x.
Normal preoperative tests were performed. An abdom-
inal computed tomography revealed a complex mass in the 
pelvis, extending to mesogastrium; mild bilateral hydrone-
phrosis; and presence of free uid in the pelvis (Figure 1). 
The patient underwent laparotomy, with collection of 
ascitic uid for oncologic cytology. A complex cyst was 
found in the right ovary, weighing 680 g, multiseptated, 
with areas of capsular rupture. A right salpingo-oopho-
rectomy was performed, and the material was sent for 
frozen section examination, diagnosed malignant. The 
le ovary showed increased volume with cystic areas 
(Figure 2).
Aer the family’s consent, a biopsy of the le ovary 
was performed, with frozen section examination, which 
was also positive for malignancy, followed by le salpin-
go-oophorectomy, omentectomy, and periaortic and bi-
lateral pelvic lymphadenectomy.
The patient had no complications in the postoperative 
period and was discharged in three days. She returned for 
removal of stitches, without incident.
The pathological report revealed a grade 3 immature 
teratoma; lymph nodes and omentum free of neoplastic 
involvement (Figure 3); ascitic uid positive for malig-
nant neoplastic cells (FIGO stage 1C G3).
The patient was referred to the Clinical Oncology 
Department for adjuvant chemotherapy and received 
six cycles of vincristine/actinomycin/cyclophosphamide 
(VAC). Currently, she is being followed-up every six 
months without evidence of disease.
DISCUSSION
Bilateral immature teratoma is a rare condition, account-
ing for 10% of cases3. Bilateral tumors are most ofien as-
sociated with advanced staging, having a five-year survival 
rate of 80.7%, compared with a survival rate of 93.6% for 
unilateral tumors13.
The degree of cell immaturity (grade 3) is another ad-
verse prognostic factor, with high rate of reincidence14. 
These factors justify the radical approach taken, to the 
detriment of the patient’s reproductive future. Some au-
thors advocate conservative treatment in germ cell tumors 
grades 1 and 215. The tumor marker most commonly relat-
ed to immature teratoma is alpha-fetoprotein3. Diagnosis 
of immature ovarian teratoma by tumor markers appears 
to be more sensitive when combined with detection of 
Ca125, Ca153, and alpha-fetoprotein16.
Imaging diagnosis of immature teratoma appear simi-
lar to mature teratoma due to its cystic appearance with fat 
content. One way to distinguish them would be the pres-
ence of contrast on computed tomography or magnetic 
resonance imaging17.
The literature on immature teratoma, particularly bi-
lateral, is limited. There are few cases reported in retro-
spective descriptions of isolated cases or small series. The 
importance of timely diagnosis in cases of pelvic masses 
in the adolescent patient must be emphasized, in order to 
provide early and adequate treatment, thus causing the 
least possible impact on the reproductive future of these 
young women.
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